Despite left ventricular (LV) dysfunction contributing to mortality in chronic heart failure (HF), the molecular mechanisms of LV failure continues to remain poorly understood and myocardial biomarkers have yet to be identified. The aim of this pilot study was to investigate specific transcriptome changes occurring in cardiac tissues of patients with HF compared to healthy condition patients to improve diagnosis and possible treatment of affected subjects
Background: Right ventricular (RV) dysfunction contributes to mortality in chronic heart failure (HF...
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher p...
Data from: "The Reference of the Transcriptional Landscape of Human End-Stage Heart Failure" Source...
Background: Despite left ventricular (LV) dysfunction contributing to mortality in chronic heart fai...
Abstract Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly...
Abstract Background Current heart failure (HF) treatment is based on targeting symptoms and left ven...
Objective: To assess the global changes in and characteristics of the transcriptome of long noncodin...
Dilated cardiomyopathy (DCM) is a progressive disease of heart muscle leading to end-stage heart fai...
Background: Long noncoding RNAs (lncRNAs) are non-protein coding transcripts regulating a variety of...
OBJECTIVE: To assess the global changes in and characteristics of the transcriptome of long noncodin...
Background: Morbidity and mortality of heart failure (HF) post-myocardial infarction (MI) remain ele...
Objective: To assess the global changes in and characteristics of the transcriptome of long noncodin...
AIM: Heart disease is recognized as a consequence of dysregulation of cardiac gene regulatory networ...
Abstract BACKGROUND: Heart failure (HF) is the most common cause of morbidity and mortality in ...
Aims: Chronic heart failure (CHF) is a systemic syndrome with a poor prognosis and a need for novel ...
Background: Right ventricular (RV) dysfunction contributes to mortality in chronic heart failure (HF...
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher p...
Data from: "The Reference of the Transcriptional Landscape of Human End-Stage Heart Failure" Source...
Background: Despite left ventricular (LV) dysfunction contributing to mortality in chronic heart fai...
Abstract Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly...
Abstract Background Current heart failure (HF) treatment is based on targeting symptoms and left ven...
Objective: To assess the global changes in and characteristics of the transcriptome of long noncodin...
Dilated cardiomyopathy (DCM) is a progressive disease of heart muscle leading to end-stage heart fai...
Background: Long noncoding RNAs (lncRNAs) are non-protein coding transcripts regulating a variety of...
OBJECTIVE: To assess the global changes in and characteristics of the transcriptome of long noncodin...
Background: Morbidity and mortality of heart failure (HF) post-myocardial infarction (MI) remain ele...
Objective: To assess the global changes in and characteristics of the transcriptome of long noncodin...
AIM: Heart disease is recognized as a consequence of dysregulation of cardiac gene regulatory networ...
Abstract BACKGROUND: Heart failure (HF) is the most common cause of morbidity and mortality in ...
Aims: Chronic heart failure (CHF) is a systemic syndrome with a poor prognosis and a need for novel ...
Background: Right ventricular (RV) dysfunction contributes to mortality in chronic heart failure (HF...
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher p...
Data from: "The Reference of the Transcriptional Landscape of Human End-Stage Heart Failure" Source...